Opin vísindi

Browsing by Author "Ingason, Arnar Bragi"

Browsing by Author "Ingason, Arnar Bragi"

Sort by: Order: Results:

  • Icon
    Comparison of medication adherence to different oral anticoagulants : population-based cohort study 
    Ingason, Arnar Bragi; Hreinsson, Jóhann P.; Lund, Sigrún Helga; Ágústsson, Arnar Snær; Rumba, Edward; Pálsson, Daníel; Reynisson, Indriði E.; Guðmundsdóttir, Brynja R; Önundarson, Páll Torfi; Björnsson, Einar Stefán (2023-01-01)
    OBJECTIVE: Previous observational studies have yielded conflicting results on whether medication adherence differs between patients receiving warfarin and direct oral anticoagulants (DOACs). Importantly, no study has adequately accounted for warfarin ...
  • Icon
    Comparison of the effectiveness and safety of direct oral anticoagulants: nationwide propensity score-weighted study 
    Ingason, Arnar Bragi; Hreinsson, Johann Pall; Agustsson, Arnar Snaer; Lund, Sigrun Helga; Rumba, Edward; Palsson, Daniel Alexander; Reynisson, Indridi Einar; Guðmundsdóttir, Brynja R; Önundarson, Páll Torfi; Björnsson, Einar Stefán (2022-12-23)
  • Icon
    Comparison of the efficacy, safety, and adherence of oral anticoagulants 
    Ingason, Arnar Bragi (University of Iceland, School of Health Sciences, Faculty of Medicine, 2022-05-27)
    Oral anticoagulants (OACs) are among the most commonly used medication worldwide. Vitamin K antagonists, such as warfarin, were the only available oral anticoagulants for over 60 years. However, in the 2010s, novel direct oral anticoagulants (DOACs) ...
  • Icon
    Ópíóíðaeitrun í kjölfar vórikónazólmeðferðar - sjúkratilfelli 
    Ingason, Arnar Bragi; Magnússon, Magnús Karl; Ragnarsson, Gunnar Bjarni (2019-08)
    67 ára gömul kona, sem tók langverkandi ópíóíðalyf (oxýkódon) vegna langvarandi brjóstverkja, varð fyrir bráðri ópíóíðaeitrun eftir að hafin var meðferð með vórikónazóli. Vórikónazól er sveppalyf sem getur bælt virkni CYP3A4 sem er niðurbrotsensím í ...